Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Matinas BioPharma (MTNB) stocks in Canada
Learn how to easily invest in Matinas BioPharma stocks.
Matinas BioPharma is a biotechnology business based in the US. Matinas BioPharma stocks (MTNB.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.7424 – an increase of 3.45% over the previous week. Matinas BioPharma employs 20 staff and has a trailing 12-month revenue of around $95,833.
How to buy shares in Matinas BioPharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MTNB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Matinas BioPharma?
- Has coronavirus impacted Matinas BioPharma shares?
- Matinas BioPharma shares summary
- Compare share dealing platforms
- Is Matinas BioPharma stock a buy or sell?
- Matinas BioPharma performance over time
- Matinas BioPharma's financials
- How volatile are Matinas BioPharma shares?
- Does Matinas BioPharma pay a dividend?
- Other common questions
Matinas BioPharma stock price (NYSE MKT:MTNB)Use our graph to track the performance of MTNB stocks over time.
Matinas BioPharma shares at a glance
|Latest market close||$0.90|
|52-week range||$0.67 - $1.73|
|50-day moving average||$1.02|
|200-day moving average||$0.93|
|Wall St. target price||$2.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.11|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Matinas BioPharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Matinas BioPharma price performance over time
|1 week (2022-01-13)||3.45%|
|1 month (2021-12-20)||-14.29%|
|3 months (2021-10-20)||-21.05%|
|6 months (2021-07-20)||27.30%|
|1 year (2021-01-20)||-43.75%|
|2 years (2020-01-17)||-39.60%|
|3 years (2019-01-18)||1.12|
|5 years (2017-01-20)||2|
Matinas BioPharma financials
|Gross profit TTM||$-14,200,585|
|Return on assets TTM||-21.61%|
|Return on equity TTM||-36.26%|
|Market capitalisation||$189.2 million|
TTM: trailing 12 months
Matinas BioPharma share dividends
We're not expecting Matinas BioPharma to pay a dividend over the next 12 months.
Matinas BioPharma share price volatility
Over the last 12 months, Matinas BioPharma's shares have ranged in value from as little as $0.668 up to $1.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Matinas BioPharma's is 2.1394. This would suggest that Matinas BioPharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Matinas BioPharma overview
Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nano-crystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 free fatty acid formulation for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections.
Stocks similar to Matinas BioPharma
Matinas BioPharma in the news
Matinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, 2022
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.